CH:C9DF Holdings Information

Compare

Holdings Count

Total Assets

79.71M

Top 10 Percentage

42.55%

Asset Class

Equity

Top Holdings

26 Holdings as of Apr 09, 2026

IMCD

IMCD N.V.

4.75%

$3.65M

―

€5.42B

-23.42%

3 Buy

2 Hold

0 Sell

Moderate Buy

―

DPLM

Diploma plc

4.66%

$3.59M

―

£8.98B

73.11%

7 Buy

3 Hold

0 Sell

Moderate Buy

―

IOS

IONOS Group SE

4.39%

$3.38M

―

€3.32B

-13.61%

6 Buy

2 Hold

0 Sell

Strong Buy

―

REC

Recordati Industria Chimica e Farmaceutica SPA

4.28%

$3.29M

―

€10.08B

2.48%

2 Buy

1 Hold

0 Sell

Moderate Buy

―

DIM

Sartorius Stedim Biotech

4.12%

$3.17M

―

€16.58B

1.88%

7 Buy

1 Hold

0 Sell

Strong Buy

―

CRDA

Croda International

4.09%

$3.15M

―

£4.14B

9.93%

4 Buy

2 Hold

0 Sell

Moderate Buy

―

ROVI

Laboratorios Farmaceuticos Rovi

4.08%

$3.14M

―

€4.21B

71.42%

1 Buy

1 Hold

0 Sell

Moderate Buy

―

ZTS

Zoetis

4.08%

$3.14M

―

$49.75B

-20.39%

6 Buy

6 Hold

0 Sell

Moderate Buy

―

SCR

SCOR SE (UK)

4.06%

$3.13M

―

€5.75B

29.90%

4 Buy

3 Hold

0 Sell

Moderate Buy

―

ASRNL

ASR Nederland N.V

4.05%

$3.11M

―

€12.76B

18.41%

3 Buy

3 Hold

0 Sell

Moderate Buy

―

Rows:

C9DF ETF News

PremiumBlurbs

IMCD N.V. (0QVU) Receives a Buy from Barclays

16h ago

PremiumBlurbs

RBC Capital Keeps Their Buy Rating on Sartorius Stedim Biotech (0RG8)

22h ago

PremiumCompany Announcements

Croda Executives Receive Shares Under Incentive Plan

1d ago

PremiumCompany Announcements

Recordati Publishes Candidate Lists for New Board of Statutory Auditors Ahead of April Meeting

6d ago

See More CH:C9DF News

C9DF ETF FAQ

What are ETF CH:C9DF’s top 3 holdings?

CH:C9DF’s top 3 holdings are NL:IMCD, GB:DPLM, DE:IOS.

What is ETF CH:C9DF’s holdings count?

ETF CH:C9DF’s is holdings 26 different assets.

What are the total assets of ETF CH:C9DF?

ETF CH:C9DF’s total assets are 79.71M.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing